エピソード

  • Legaltech Insights: AI's Role in Law & Medicine with Heidi's $465M Valuation

    Legaltech Insights: AI's Role in Law & Medicine with Heidi's $465M Valuation
    2025/12/24

    Welcome to the Legaltech News Podcast, where we delve into the dynamic intersection of law and technology. Stay informed with our expert analysis on the latest trends in legal tech, from AI integration in legal processes to tackling cybersecurity threats. Discover how legal departments can boost efficiency and cut costs, while law firms enhance client services with innovative tools. We also spotlight tech companies driving change in the legal sector.

    In today's episode, we explore Dr. Thomas Kelly's inspiring journey from medicine to legaltech innovation. After leaving his medical career, Kelly developed AI tools like Heidi, an AI medical scribe, to ease doctors' administrative burdens. His venture has attracted significant funding, highlighting AI's transformative potential in traditional fields.

    Join us as we provide the insights you need to navigate the rapidly evolving legal tech landscape and make informed decisions.

    Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture.

    As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics.

    Start your VoiceStream free trial today!

    Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today!

    📚 Sources:
    • https://www.law.com/2025/12/24/health-care-and-life-science-stakeholders-value-ai-for-regulatory-monitoring/
    • https://www.cnbc.com/2025/12/24/he-left-medicine-to-build-an-ai-tool-now-its-worth-460-million.html
    続きを読む 一部表示
    4 分
  • Novo Nordisk's Wegovy Pill Approved; AI in Pharma; Kaiser EHR Success; Chai's $130M Boost

    Novo Nordisk's Wegovy Pill Approved; AI in Pharma; Kaiser EHR Success; Chai's $130M Boost
    2025/12/23
    In this episode, we explore the latest developments in the pharmaceutical and healthcare sectors. The FDA has approved an oral version of Novo Nordisk’s Wegovy, potentially increasing accessibility for patients seeking weight-loss solutions. The pharmaceutical industry is undergoing significant changes, with major mergers and regulatory shifts shaping its future. Medicus Pharma Ltd. is collaborating with Reliant AI Inc. to enhance clinical trial efficiency through AI-driven analytics. The U.S. government is leveraging AI for biotech and biodefense advancements, raising biosecurity concerns. The FDA is integrating AI to streamline operations and improve decision-making. Medtech mergers and acquisitions are expected to accelerate, focusing on AI and data-driven capabilities. Chai has secured $130 million to advance AI-driven drug discovery, aiming to revolutionize healthcare. A controversial cancer diet is being reconsidered for its potential benefits, sparking debate among medical professionals. The FDA is addressing AI monitoring in medical devices, emphasizing real-world performance. Lastly, Kaiser Permanente successfully consolidated its electronic health record systems, setting a precedent for future health system projects. Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.statnews.com/2025/12/22/hhs-proposes-scrapping-ai-model-cards-transparency-rule/https://www.mmm-online.com/news/2025-the-year-in-pharma-tariffs-mergers-and-regulatory-volatility/https://drug-dev.com/medicus-pharma-announces-engagement-with-reliant-ai-to-develop-ai-driven-clinical-data-analytics-platform/https://councilonstrategicrisks.org/2025/12/22/2025-aixbio-wrapped-a-year-in-review-and-projections-for-2026/https://www.fiercebiotech.com/ai-and-machine-learning/fda-adopts-agentic-ai-latest-push-infuse-agency-artificial-intelligencehttps://www.medtechdive.com/news/pitchbook-merger-acquisition-acceleration-2026/806872/https://www.fiercebiotech.com/biotech/chai-infuses-ai-drug-discovery-efforts-130m-series-bhttps://www.statnews.com/2025/12/15/mammogram-ai-predictive-models-both-breast-cancer-heart-disease/https://www.medtechdive.com/news/fda-comments-ai-performance-monitoring/807995/https://medcitynews.com/2025/12/kaiser-permanente-ehr/
    続きを読む 一部表示
    11 分
  • AI Revolutionizes Healthcare: From Diagnostics to FDA Approvals and MedTech Innovations

    AI Revolutionizes Healthcare: From Diagnostics to FDA Approvals and MedTech Innovations
    2025/12/22

    Welcome to the AI in Healthcare podcast, where we explore the transformative impact of artificial intelligence on the medical industry. AI is rapidly reshaping healthcare, with a projected compound annual growth rate of 38.6% driven by deep learning, remote monitoring, and chronic care management. McKinsey & Company highlights the role of generative AI in streamlining back-office tasks like claims processing. AI is enhancing patient care by improving clinical workflows and patient interactions through chatbots, while also boosting clinician productivity with documentation and decision support tools. In diagnostics, AI-powered imaging tools are reducing errors, and robot-assisted surgeries are offering minimally invasive options. AI is also personalizing physical therapy and optimizing supply chain management through predictive analytics. However, equitable access to AI tools remains a concern, especially for smaller practices.

    The medtech industry is undergoing significant changes, with AI and robotics enhancing diagnostic accuracy and surgical procedures. The FDA is seeing a surge in AI-enabled medical device approvals, with 235 devices authorized in 2024 alone. AI's role in predictive analytics is growing, allowing for earlier disease detection and personalized treatments. The integration of AI in healthcare is fostering a shift towards patient-centric care models, emphasizing preventive measures and remote monitoring.

    AI is revolutionizing the medical technology industry by streamlining research and development, optimizing manufacturing processes, and transforming marketing and sales strategies. As AI becomes integral to healthcare, it offers faster, data-driven insights that improve patient outcomes and operational efficiency. This technological shift is set to redefine the healthcare industry, making it more responsive and patient-centered.

    Source URLs

    https://www.techtarget.com/searchHealthIT/feature/AI-healthcare-trends-to-watch https://www.zs.com/insights/medtech-trends-2025-healthcare-innovation https://www.medtechdive.com/news/ai-medtech-track-new-devices-fda/748397/ https://api4.ai/blog/top-10-ai-trends-shaping-the-healthcare-and-medical-industry-in-2025 https://www.scalacode.com/guides/ai-in-healthcare/ https://www.porsche-consulting.com/international/en/article/artificial-intelligence-medical-technology

    Join Stan Berteloot, a French journalist and AI expert, as he delves into these stories and more, exploring the intersection of technology and healthcare.

    Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture.

    As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics.

    Start your VoiceStream free trial today!

    Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today!
    続きを読む 一部表示
    8 分
  • Securing the Cyberworld: Seven AI's Funding Success and Mission

    Securing the Cyberworld: Seven AI's Funding Success and Mission
    2024/06/08
    This episode of 'AI in Life Sciences' presents exciting updates from the world of artificial intelligence and its game-changing applications in the Life Sciences sector. Pioneering the breakthroughs, in our first news item, Seven AI has garnered an impressive $36 million in initial funding. This considerable investment will bolster the tech company's ambition to equip businesses with AI-powered cybersecurity. As cyber threats grow more sophisticated, Seven AI's adaptive software is a remarkable step towards empowering digital defenses. Notably, Greylock took the lead in this round, boosting the cybersecurity company's value to over $100 million.
    続きを読む 一部表示
    1 分
  • Intermountain Health's AI Initiative and Regeneron's $100M Bet: Advancements in Health IT and Biomedicine

    Intermountain Health's AI Initiative and Regeneron's $100M Bet: Advancements in Health IT and Biomedicine
    2024/04/26
    "AI in Life Sciences" dives into the world where technology and biology intersect, providing expert insight and analysis on the latest trends, breakthroughs, and controversies. In this episode, we explore a potential bird flu threat in Midwestern milk, the innovative use of AI in tackling workforce shortages in healthcare, and impressive revenue growth in AstraZeneca, thanks in part to their cancer drugs. We also discuss Regeneron Pharmaceuticals’ $100M wager on Mammoth’s CRISPR technology, the crucial role of AI understanding for health IT leaders, and how AI is revolutionizing drug discovery at AION Labs. Finally, we delve into Bristol Myers Squibb’s major restructuring and its implications for employees and the company's future growth. Stay tuned for these stories and more on "AI in Life Sciences".
    続きを読む 一部表示
    5 分
  • "From Novartis' New Chair to AI Advancements: Key Insights in Pharma and Tech"

    "From Novartis' New Chair to AI Advancements: Key Insights in Pharma and Tech"
    2024/04/24
    AI in Life Sciences is a podcast that keeps a finger on the pulse of technological advancement within the healthcare and pharmaceutical fields. In this episode, we'll take a deep dive into Novartis AG's recent nomination of former Bristol Myers CEO Giovanni Caforio as incoming chair, examining what this could mean for the company's future amidst the global competition. We'll then switch gears to discuss the ongoing reorganization of AI-driven drug developer, BenevolentAI, and how shifting priorities are impacting its workforce. The episode will also cover Ultrahuman's anticipated expansion into the US market through the establishment of a manufacturing center in Indiana, a move benefiting domestic production and job creation. Finally, we'll review Basware's new AP Protect tool, designed to detect errors and fraudulent activities in finance teams using advanced AI algorithms. Join us for thought-provoking insights into how AI continues to revolutionize the life sciences sector.
    続きを読む 一部表示
    3 分
  • Advancements in AI Healthcare: ABOUT and Edgility Merger, Scopio Labs' Breakthrough, Innovaccer's HXP Launch, and GE Healthcare's Ultrasound Systems

    Advancements in AI Healthcare: ABOUT and Edgility Merger, Scopio Labs' Breakthrough, Innovaccer's HXP Launch, and GE Healthcare's Ultrasound Systems
    2024/04/21
    "AI in Life Sciences" explores the intersect of artificial intelligence (AI) and healthcare this week. We start with a discussion on the ABOUT Healthcare's merger with Edgility which it is hoped will usher in a new era of care orchestration solutions, utilizing AI and predictive analytics to optimize hospital operations and improve patient care. We then celebrate an unprecedented regulatory move in blood disorder diagnosis with Scopio Labs' FDA De Novo clearance for its Full-Field Bone Marrow Aspirate (FF-BMA) Application, a software that digitizes the analysis of bone marrow aspirate with the help of AI. Our next story analyses the abilities of Innovaccer's latest healthcare data activation platform, HXP. Born after Innovaccer's acquisition of Cured, this platform uses AI to engage patients and expedite revenue growth. Finally, we wrap up with new developments at GE HealthCare, which recently launched Voluson Signature ultrasound systems that fuse ergonomics with AI, aimed at improving women's healthcare. Tune in to stay updated on how AI continues to refine and revolutionize the healthcare industry.
    続きを読む 一部表示
    3 分
  • "AI in Supply Chain with Johns Hopkins, GLP-1s in Parkinson's Treatment, Bridging the Healthcare Divide, and Philadelphia's Safehouse Setback"

    "AI in Supply Chain with Johns Hopkins, GLP-1s in Parkinson's Treatment, Bridging the Healthcare Divide, and Philadelphia's Safehouse Setback"
    2024/04/05
    "AI in Life Sciences" takes a comprehensive look into how artificial intelligence is revolutionizing healthcare and life sciences. It covers various developments and innovations in healthcare from an AI perspective. In this episode, we discuss how AI is being used by Johns Hopkins to predict supply needs which could potentially revolutionize industry practices. We examine the role of GLP-1 molecules in Parkinson's treatment and how de-extinct species could impact medical research. Shining a spotlight on the troubling divide in the healthcare sector between payers and providers, we discuss its implications and possible solutions. Lastly, we delve into the case of Philadelphia's Safehouse and its setback after a federal judge ruled against their appeal, which could impact the fight against the city's opioid crisis. Tune in to discover more about these captivating topics.
    続きを読む 一部表示
    3 分